239 related articles for article (PubMed ID: 29200404)
21. Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.
Cross NCP; Hoade Y; Tapper WJ; Carreno-Tarragona G; Fanelli T; Jawhar M; Naumann N; Pieniak I; Lübke J; Ali S; Bhuller K; Burgstaller S; Cargo C; Cavenagh J; Duncombe AS; Das-Gupta E; Evans P; Forsyth P; George P; Grimley C; Jack F; Munro L; Mehra V; Patel K; Rismani A; Sciuccati G; Thomas-Dewing R; Thornton P; Virchis A; Watt S; Wallis L; Whiteway A; Zegocki K; Bain BJ; Reiter A; Chase A
Leukemia; 2019 Feb; 33(2):415-425. PubMed ID: 30573779
[TBL] [Abstract][Full Text] [Related]
22. Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias.
Ikeda S; Tagawa H
Int J Hematol; 2014; 99(5):542-52. PubMed ID: 24567260
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous CD4+ CD56+ hematologic malignancies.
Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
[TBL] [Abstract][Full Text] [Related]
24. Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas.
Nicolae A; Xi L; Pittaluga S; Abdullaev Z; Pack SD; Chen J; Waldmann TA; Jaffe ES; Raffeld M
Leukemia; 2014 Nov; 28(11):2244-8. PubMed ID: 24947020
[No Abstract] [Full Text] [Related]
25. The influence of STAT5 antisense oligodeoxynucleotides on the proliferation and apoptosis of selected human cutaneous T-cell lymphoma cell lines.
Baśkiewicz-Masiuk M; Walczak M; Grzegrzółka R; Rogowska D; Machaliński B
Arch Dermatol Res; 2006 Apr; 297(10):450-8. PubMed ID: 16502315
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional Regulation of Nos2 via STAT5B Binding to Nos2 Gene Promoter Mediates Nitric Oxide Production: Relevance in β-Cell Maintenance.
Joseph A; Nair LCR; Johnson BS; Thomas PL; Padmanabhan RA; Puthumadathil N; Laloraya M
Cell Physiol Biochem; 2019; 52(1):141-155. PubMed ID: 30790510
[TBL] [Abstract][Full Text] [Related]
27. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.
Siu LL; Wong KF; Chan JK; Kwong YL
Am J Pathol; 1999 Nov; 155(5):1419-25. PubMed ID: 10550295
[TBL] [Abstract][Full Text] [Related]
28. Rare occurrence of a STAT5B N642H mutation in adult T-cell acute lymphoblastic leukemia.
Ma X; Wen L; Wu L; Wang Q; Yao H; Wang Q; Ma L; Chen S
Cancer Genet; 2015; 208(1-2):52-3. PubMed ID: 25749351
[No Abstract] [Full Text] [Related]
29. Coexpression of hyperactivated AKT1 with additional genes activated in leukemia drives hematopoietic progenitor cells to cell cycle block and apoptosis.
Tang Y; Halvarsson C; Nordigården A; Kumar K; Åhsberg J; Rörby E; Wong WM; Jönsson JI
Exp Hematol; 2015 Jul; 43(7):554-64. PubMed ID: 25931014
[TBL] [Abstract][Full Text] [Related]
30. Role of epigenetic changes in hematological malignancies.
Lehmann U; Brakensiek K; Kreipe H
Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862
[TBL] [Abstract][Full Text] [Related]
31. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
[TBL] [Abstract][Full Text] [Related]
32. [Molecular abnormalities in lymphomas].
Delsol G
Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
[TBL] [Abstract][Full Text] [Related]
33. A Recurrent
Kieslinger M; Swoboda A; Kramer N; Freund P; Pratscher B; Neubauer HA; Steinborn R; Wolfesberger B; Fuchs-Baumgartinger A; Moriggl R; Burgener IA
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680385
[TBL] [Abstract][Full Text] [Related]
34. Hepatosplenic T-cell lymphoma with STAT5B and SETD2 mutations recurring as cells with NK-cell immunophenotype.
Khodadoust M; Silva O
Blood; 2023 Feb; 141(5):555. PubMed ID: 36729542
[No Abstract] [Full Text] [Related]
35. Rare mutations provide unique insight into oncogenic potential of STAT transcription factors.
Heppler LN; Frank DA
J Clin Invest; 2018 Jan; 128(1):113-115. PubMed ID: 29199995
[TBL] [Abstract][Full Text] [Related]
36. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.
Knowles DM
Am J Pathol; 1989 Apr; 134(4):761-85. PubMed ID: 2495724
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.
Zhong Y; Jiang L; Hiai H; Toyokuni S; Yamada Y
Oncogene; 2007 Oct; 26(48):6937-47. PubMed ID: 17486074
[TBL] [Abstract][Full Text] [Related]
38. The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.
Zhang QL; Wang L; Zhang YW; Jiang XX; Yang F; Wu WL; Janin A; Chen Z; Shen ZX; Chen SJ; Zhao WL
Leukemia; 2009 Aug; 23(8):1507-14. PubMed ID: 19282831
[TBL] [Abstract][Full Text] [Related]
39. Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.
Zerif E; Maalem A; Gaudreau S; Guindi C; Ramzan M; Véroneau S; Gris D; Stankova J; Rola-Pleszczynski M; Mourad W; Dupuis G; Amrani A
J Autoimmun; 2017 Jan; 76():63-74. PubMed ID: 27634616
[TBL] [Abstract][Full Text] [Related]
40. Roles of germline JAK2 activation mutation JAK2 V625F in the pathology of myeloproliferative neoplasms.
Wu QY; Ma MM; Fu L; Zhu YY; Liu Y; Cao J; Zhou P; Li ZY; Zeng LY; Li F; Wang XY; Xu KL
Int J Biol Macromol; 2018 Sep; 116():1064-1073. PubMed ID: 29782975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]